home about us journals search

African Journal of Biotechnology

     
   AJB Home
   About AJB
   Submit Manuscripts
   Instructions for Authors
   Editors
   Call For Paper
   Archive
   Faculty 1000
   Conferences
   Associations

  Afr. J. Biotechnol.

  Vol. 8 No. 19

  Viewing options:

    • Abstract
    •Reprint (PDF) (208K)

  Search Pubmed for articles by:

  Zou J-P
  Du G



  Other links:
  PubMed Citation
  Related articles in PubMed

Related Journals
African Journal of Agricultural Research
African Journal  of Environmental Science & Technology
Biotechnology & Molecular Biology Reviews

African Journal of Biochemistry Research

African Journal of Microbiology Research
African Journal of Pure & Applied Chemistry
African Journal of Food Science
Journal of Cell & Animal Biology
African Journal of Pharmacy & Pharmacology

African Journal of Plant Science
Journal of Medicinal Plant Research
International Journal of Physical Sciences
Scientific Research and Essays
 

African Journal of Biotechnology Vol. 8 (19), pp. 5132-5136, 5 October 2009

ISSN 1684-5315  © 2009 Academic Journals  

 

 

Full Length Research Paper

 

Solubilization and purification of Escherichia coli expressed GST-fusion human vascular endothelial growth factors with

N-Lauroylsarcosine

 

Jian-ping Zou1,2, Jing Xu3, Licheng Liu4, Shuxiang Li3, Chunfu Wu1 and Guanhua Du1*

 

1Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang, P.R. China 110016.

2Beijing JPJX Bio-Med Co. Ltd, Beijing, P. R. China 100085.

3Department of Immunology, National Vaccine and Serum Institute, 4 Sanjianfang Nanli, Beijing, P. R. China 100024.

4Department of Biochemistry, College of Life Sciences, Lanzhou University,

Lanzhou, P. R. China 730000.

 

*Corresponding author. E-mail: dugh@imm.ac.cn. Tel.: ++861063165184.

Fax: ++861063165184.

 

Accepted 3 March, 2009

 

   Abstract

 

Vascular endothelial growth factor (VEGF) is a potent mitogen for tumor angiogenesis. Clinically, VEGF detection in human blood can be expected to be used in the very near future for cancer screening, prognosis, monitoring of therapy and diagnosis. VEGF has been identified as the target for the treatment of cancer. Though prokaryotic expression of VEGF has been done, the solubilization and purification is time consuming and empirical. In this study, VEGF165 and VEGF121 were cloned into pGEX-4T-1 vector, and GST-VEGF fusion proteins were expressed in Escherichia coli at 37°C. The inclusion bodies of GST-VEGF fusion proteins were solubilized with N-Lauroylsarcosine (sarkosyl). Briefly, the cell suspension with inclusion body was added with sarkosyl at a final concentration of 1.5%. After the disruption of cells, the clarified supernatant containing sarkosyl was added with Triton X-100 at a final concentration of 3%. The GST-VEGFs were purified by affinity chromatography on glutathione Sepharose 4B. The overall yield was approximately 10 – 12 mg/l cell culture. The binding assay showed that the GST-VEGF165 binds to VEGF receptor in a dose dependent manner. The current work provides a novel procedure for solubilization and purification of GST-VEGF fusion proteins, and no laborious procedures for separation of inclusion bodies and renaturation were needed.

 

Key words: VEGF, sarkosyl, solubilization, purification, GST.

___________________________________________________________________________________________________________

Advertise on AJB | Terms of Use | Privacy Policy | Help

© Academic Journals 2002 - 2009